Jean‐François Korobelnik

Université de Bordeaux — France

Medicine · Health Sciences

55h-index16.0kcitations468works10.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(230), Retinal Imaging and Analysis(146), Retinal and Optic Conditions(120), Glaucoma and retinal disorders(103), Retinal and Macular Surgery(60)

Publications463 total

Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years
Ophthalmologica·2025Open Access
Retinal Microvascular Correlates of Cerebral Small Vessel Disease in Older Age
Neurology·2025· 4 citedOpen Access
BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials [Building Research Innovations and Developing Global Endpoints]
Eye·2025Open Access
Recommandations pour l’utilisation raisonnée des nouvelles molécules anti-VEGF
Journal Français d Ophtalmologie·2025
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies
Immunotherapy·2025· 1 citedOpen Access
Neuroretinal and Retinal Pigment Epithelium Changes and Susceptibility to Age-Related Macular Degeneration
Ophthalmology·2025· 5 citedOpen Access
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
Ophthalmology and Therapy·2024· 4 citedOpen Access
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff
Ophthalmology and Therapy·2024· 6 citedOpen Access
Ambient air pollution exposure and incidence of cataract surgery: The prospective 3City‐Alienor study
Acta Ophthalmologica·2024· 7 citedOpen Access
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Eye·2024· 7 citedOpen Access
Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases
Eye·2024· 6 citedOpen Access
Association of Lipopolysaccharide-Type Endotoxins with Retinal Neurodegeneration: The Alienor Study
Ophthalmology Science·2024· 3 citedOpen Access
Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration
British Journal of Ophthalmology·2024· 6 citedOpen Access
Associations of circulating vitamins with 10-year retinal neurodegeneration: the Alienor Study
The journal of nutrition health & aging·2024· 1 citedOpen Access
Long-term blood pressure variability and risk of age-related macular degeneration in older adults: The ALIENOR study
Archives of cardiovascular diseases·2024
BCVA gains with aflibercept 8 mg maintained through Week 96 in PULSAR with extended treatment intervals in patients with nAMD
SPIRE - Sciences Po Institutional REpository·2024
Dietary patterns of polyphenols and risk of advanced age-related macular degeneration: the Alienor study
SPIRE - Sciences Po Institutional REpository·2024
Use of infracyanine green with angiography imaging
SPIRE - Sciences Po Institutional REpository·2024
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
The Lancet·2024· 183 cited
Expert Consensus on Geographic Atrophy in the EU: A Call for Urgent Policy Action
Ophthalmology and Therapy·2024· 2 citedOpen Access
page 1 of 24Next →

Frequent Co-authors

Cécile Delcourt(17), Frank G. Holz(14), Marie‐Noëlle Delyfer(14), Audrey Cougnard‐Grégoire(12), Robert Vitti(11), Catherine Creuzot‐Garcher(11), Caroline C. W. Klaver(11), Marie‐Bénédicte Rougier(11), Alyson J. Berliner(10), Ursula Schmidt‐Erfurth(10), Jeffrey S. Heier(9), Christian Simader(9), Oliver Zeitz(9), B. Merle(9), Johanna M. Colijn(8), Paul J. Foster(8), Carel B. Hoyng(8), Mélanie Le Goff(8), Timo Verzijden(7), Peter K. Kaiser(6)